These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21763923)

  • 1. Treatment as prevention--a double hat-trick.
    Montaner JS
    Lancet; 2011 Jul; 378(9787):208-9. PubMed ID: 21763923
    [No Abstract]   [Full Text] [Related]  

  • 2. Survival and progression to AIDS in a seroconverter cohort in the post-highly active antiretroviral therapy era: effectiveness goes on.
    Pérez-Hoyos S; Ferreros I; del Amo J; Muga R; del Romero J; de Olalla PG; Hernández-Aguado I
    AIDS; 2006 Jan; 20(2):289-91. PubMed ID: 16511426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness of combined antiretroviral therapy on multiple AIDS-defining illnesses in an HIV seroconverter cohort].
    Ferreros I; Hurtado I; del Amo J; Muga R; del Romero J; García P; Alastrué I; Belda J; Guevara M; Pérez S;
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):179-84. PubMed ID: 21333403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidemiological and clinical development of HIV+ patients followed by the Lausanne University Hospital Center from 1982 to 1992].
    Beck C; Chave JP; Glauser MP
    Rev Med Suisse Romande; 1994 Dec; 114(12):1067-74. PubMed ID: 7817069
    [No Abstract]   [Full Text] [Related]  

  • 5. Effectiveness of antiretroviral therapy in HIV-1-infected active drug users attended in a drug abuse outpatient treatment facility providing a multidisciplinary care strategy.
    Sánchez GV; Llibre JM; Torrens M; Sanvisens A; Mateu G; Knobel H; Langohr K; Santos JR; Muga R
    Curr HIV Res; 2012 Jun; 10(4):356-63. PubMed ID: 22591359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological characteristics on human immunodeficiency virus infection and acquired immunodeficiency syndrome in Japan.
    Miyazaki M; Naemura M
    Int J STD AIDS; 1994; 5(4):273-8. PubMed ID: 7948158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Free interpretations of facts on the HIV epidemic among drug addicts].
    Tunving K
    Lakartidningen; 1991 Jul; 88(30-31):2505-6. PubMed ID: 1865715
    [No Abstract]   [Full Text] [Related]  

  • 8. Tuberculosis control in South Africa--will HAART help?
    Lawn SD; Wood R
    S Afr Med J; 2006 Jun; 96(6):502-4. PubMed ID: 16841129
    [No Abstract]   [Full Text] [Related]  

  • 9. [AIDS and HIV in Sweden. The figures in a 10-year perspective].
    Böttiger M; Eriksson G
    Lakartidningen; 1992 Mar; 89(12):963-5. PubMed ID: 1552790
    [No Abstract]   [Full Text] [Related]  

  • 10. Effectiveness of highly active antiretroviral therapy in Spanish cohorts of HIV seroconverters: differences by transmission category.
    Pérez-Hoyos S; del Amo J; Muga R; del Romero J; García de Olalla P; Guerrero R; Hernàndez-Aguado I;
    AIDS; 2003 Feb; 17(3):353-9. PubMed ID: 12556689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Explosive spread and effective control of human immunodeficiency virus in northernmost Thailand: the epidemic in Chiang Rai province, 1988-99.
    Kilmarx PH; Supawitkul S; Wankrairoj M; Uthaivoravit W; Limpakarnjanarat K; Saisorn S; Mastro TD
    AIDS; 2000 Dec; 14(17):2731-40. PubMed ID: 11125892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opportunistic infections after the initiation of highly active antiretroviral therapy in advanced AIDS patients in an area with a high prevalence of tuberculosis.
    Sungkanuparph S; Vibhagool A; Mootsikapun P; Chetchotisakd P; Tansuphaswaswadikul S; Bowonwatanuwong C
    AIDS; 2003 Sep; 17(14):2129-31. PubMed ID: 14502020
    [No Abstract]   [Full Text] [Related]  

  • 13. Is there a role for contact tracing in preventing HIV transmission among injecting drug users?
    Hall W; Dolan K
    Addiction; 1996 Jul; 91(7):917-9. PubMed ID: 8688821
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease.
    Graham NM; Galai N; Nelson KE; Astemborski J; Bonds M; Rizzo RT; Sheeley L; Vlahov D
    Arch Intern Med; 1996 Apr; 156(8):889-94. PubMed ID: 8774208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Battles with donors cloud Malawi's HIV prevention plan.
    Donnelly J
    Lancet; 2011 Jul; 378(9787):215-6. PubMed ID: 21770061
    [No Abstract]   [Full Text] [Related]  

  • 16. Report on the Fifth Conference on Retroviruses and Opportunistic Infections.
    Soloway B
    AIDS Clin Care; 1998 Apr; 10(4):27-9. PubMed ID: 11365150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [News in HIV/AIDS therapy].
    Calmy A; Cavassini M
    Rev Med Suisse; 2012 Jan; 8(324):130-4. PubMed ID: 23185824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited effect of highly active antiretroviral therapy among HIV-positive injecting drug users on the population level.
    van Asten LC; Boufassa F; Schiffer V; Brettle RP; Robertson JR; Hernández Aguado I; McMenamin J; Zangerle R; Fontanet A; Coutinho RA; Prins M
    Eur J Public Health; 2003 Dec; 13(4):347-9. PubMed ID: 14703322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review editorial: prevention of tuberculosis in resource-poor countries with increasing access to highly active antiretroviral treatment.
    Apers L; Lynen L; Worodria W; Colebunders R
    Trop Med Int Health; 2005 Dec; 10(12):1209-14. PubMed ID: 16359399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2001 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus.
    US Public Health Service, Infectious Diseases Society of America, Prevention of Opportunistic Infections Working Group
    Infect Dis Obstet Gynecol; 2002; 10(1):3-64. PubMed ID: 12090361
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.